Top

Published in:

01-05-2017 | SYMPOSIUM - NUTRACEUTICS AND HEADACHE

Usefulness of nutraceuticals in migraine prophylaxis

Authors: Florindo D’Onofrio, Simona Raimo, Daniele Spitaleri, Gerardo Casucci, Gennaro Bussone

Published in: Neurological Sciences | Special Issue 1/2017

Abstract

Several studies have supported the efficacy of complementary and alternative medicine approaches (physical, behavioral and nutraceutical therapies) in the treatment of headache disorders. Nutraceutical treatment consists of taking vitamins, supplements (magnesium, riboflavin, coenzyme Q10, and alpha lipoic acid) and herbal preparations (feverfew and butterbur), and its usage is frequently determined by dissatisfaction with conventional medical therapies. There is a growing body of research on nutraceutical use for migraine prophylaxis. This brief overview provides information about the potential efficacy and side effects of various nutraceutical products summarizing randomized controlled trials of some of the most commonly used non-pharmacological treatments for the prophylaxis and treatment of migraine, including magnesium, coenzyme Q10, riboflavin (vitamin B₂), petasites, and feverfew.

Kalra EK (2003) Nutraceutical—definition and introduction. AAPS Pharm Sci 5:27–28CrossRef

Sun-Edelstein C, Mauskop A (2011) Alternative headache treatments: nutraceuticals, behavioral and physical treatments. Headache 51(3):469–483CrossRefPubMed

Daniel O, Mauskop A (2016) Nutraceuticals in acute and prophylactic treatment of migraine. Curr Treat Options Neurol 18(4):14CrossRefPubMed

Kandasamy AD (2014) Nutraceuticals for the treatment of migraine prophylaxis. Discov Phytomed 1:16–21CrossRef

D’Amico D, Tepper SJ (2008) Prophylaxis of migraine: general principles and patient acceptance. Neuropsychiatr Dis Treat 4(6):1155–1167CrossRefPubMedPubMedCentral

Rybicka JM, Balce DR, Chaudhuri S, Allan ERO, Yates RM (2012) Phagosomal proteolysis in dendritic cells is modulated by NADPH oxidase in a pH-independent manner. EMBO J 31(4):932–944CrossRefPubMed

Gaul C, Diener HC, Danesch U; Migravent^® Study Group (2015) Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial. J Headache Pain 16:516

Mauskop A, Altura BT, Altura BM (2002) Serum ionized magnesium levels and serum ionized calcium/ionized magnesium ratios in women with menstrual migraine. Headache 42:242–248CrossRefPubMed

Chiu HY, Yeh TH, Huang YC, Chen PY (2016) Effects of intravenous and oral magnesium on reducing migraine: a meta-analysis of randomized controlled trials. Pain Physician 19(1):E97–E112PubMed

10.

Teigen L, Boes CJ (2015) An evidence-based review of oral magnesium supplementation in the preventive treatment of migraine. Cephalalgia 35(10):912–922CrossRefPubMed

11.

Schoenen J, Jacquy J, Lenaerts M (1998) Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 50(2):466–470CrossRefPubMed

12.

Sandor PS, Afra J, Ambrosini A, Schoenen J (2000) Prophylactic treatment of migraine with beta-blockers and riboflavin: differential effects on the intensity dependence of auditory evoked cortical potentials. Headache 40:30–35CrossRefPubMed

13.

Boehnke C, Reuter U, Flach U, Schuh-Hofer S, Einhäupl KM, Arnold G (2004) High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre. Eur J Neurol 11(7):475–477CrossRefPubMed

14.

MacLennan SC, Wade FM, Forrest KM, Ratanayake PD, Fagan E, Antony J (2008) High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial. J Child Neurol 23(11):1300–1304CrossRefPubMed

15.

Grossmann M, Schmidramsl H (2000) An extract of Petasites hybridus is effective in the prophylaxis of migraine. Int J Clin Pharmacol Ther 38(9):430–435CrossRefPubMed

16.

Diener HC, Rahlfs VW, Danesch U (2004) The first placebo-controlled trial of a special butterbur root extract for the prevention of migraine: reanalysis of efficacy criteria. Eur Neurol 51(2):89–97CrossRefPubMed

17.

Lipton RB, Göbel H, Einhäupl KM, Wilks K, Mauskop A (2004) Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology 63(12):2240–2244CrossRefPubMed

18.

Pothmann R, Danesch U (2005) Migraine prevention in children and adolescents: results of an open study with a special butterbur root extract. Headache 45(3):196–203CrossRefPubMed

19.

Utterback G, Zacharias R, Timraz S, Mershman D (2014) Butterbur extract: prophylactic treatment for childhood migraines. Complement Ther Clin Pract 20(1):61–64CrossRefPubMed

20.

Diener HC, Pfaffenrath V, Schnitker J, Friede M, Henneicke-von Zepelin HH (2005) Efficacy and safety of 6.25 mg t.i.d. feverfew CO₂-extract (MIG-99) in migraine prevention—a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia 25(11):1031–1041CrossRefPubMed

21.

Pittler MH, Ernst E (2004) Feverfew for preventing migraine. Cochrane Database Syst Rev 1:CD002286

22.

Sandor PS, Di Clemente L, Coppola G, Saenger U, Fumal A, Magis D, Seidel L, Agosti RM, Schoenen J (2005) Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology 64(4):713–715CrossRefPubMed

23.

Rozen TD, Oshinsky ML, Gebeline CA, Bradley KC, Young WB, Shechter AL, Silberstein SD (2002) Open label trial of coenzyme Q10 as a migraine preventive. Cephalalgia 22(2):137–141CrossRefPubMed

24.

Shoeibi A, Olfati N, Soltani Sabi M, Salehi M, Mali S, Akbari Oryani M (2016) Effectiveness of coenzyme Q10 in prophylactic treatment of migraine headache: an open-label, add-on, controlled trial. Acta Neurol Belg 117:103–109CrossRefPubMed

25.

Slater SK, Nelson TD, Kabbouche MA, LeCates SL, Horn P, Segers A, Manning P, Powers SW, Hershey AD (2011) A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine. Cephalalgia 31(8):897–905CrossRefPubMed

26.

Cady RK, Goldstein J, Nett R, Mitchell R, Beach ME, Browning R (2011) A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic™ M) in the treatment of migraine. Headache 51(7):1078–1086CrossRefPubMed

27.

D’Andrea G, Bussone G, Allais G, Aguggia M, D’Onofrio F, Maggio M, Moschiano F, Saracco MG, Terzi MG, Petretta V, Benedetto C (2009) Efficacy of Ginkgolide B in the prophylaxis of migraine with aura. Neurol Sci 1:S121–S124CrossRef

28.

Orr SL, Friedman BW, Christie S, Minen MT, Bamford C, Kelley NE, Tepper D (2016) Management of adults with acute migraine in the emergency department: the American Headache Society evidence assessment of parenteral pharmacotherapies. Headache 56(6):911–940CrossRefPubMed

Title: Usefulness of nutraceuticals in migraine prophylaxis
Authors: Florindo D’Onofrio
Simona Raimo
Daniele Spitaleri
Gerardo Casucci
Gennaro Bussone
Publication date: 01-05-2017
Publisher: Springer Milan
Published in: Neurological Sciences / Issue Special Issue 1/2017
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-017-2901-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Usefulness of nutraceuticals in migraine prophylaxis

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 1/2017

Migraine with aura white matter lesions: preliminary data on clinical aspects

POSTERS

Intravenous mannitol in status migrainosus treatment: a clinical case series

The role of anti-CGRP antibodies in the pathophysiology of primary headaches

Behavioral therapy: emotion and pain, a common anatomical background

Headache and arterial hypertension